Furthermore, in the present study, we observed interactions between simvastatin, AT1 antagonists, and ROCK inhibitors in the substantia nigra and striatum of rats with LID, which may explain why the three treatments reduce dyskinesia. This evidence concerns the gene AGTR1 and Dyskinesia.